United States Pharmacopeial Convention Inc is a 501(c)(3) organization based in Rockville, Maryland, registered in 1959, with $357,720,644 in FY2024 revenue. CharityIndex grades it A, and it directs about 71% of spending to programs.
Revenue (FY2024)
$357.7M
▲ 1.1% vs prior year
Health median: $840K
Expenses (FY2024)
$333.6M
Net assets
$606.6M
Employees
941
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For United States Pharmacopeial Convention Inc: 71% to programs · $4 to raise $100 earns a B on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For United States Pharmacopeial Convention Inc: 22 mo reserves · +7% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For United States Pharmacopeial Convention Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For United States Pharmacopeial Convention Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To improve the health of people around the world through public standards and (see schedule o) related programs that help ensure the quality, safety, and benefit of medicines and foods.
Non-compendial activities - see schedule o
Allied compendial activities - see schedule o
Revenue grew from $203.2M (FY2013) to $357.7M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
6.7%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$788.7M
Total liabilities
$182.0M
Net assets
$606.6M
Salaries & benefits
$181.4M
54% of expenses
Board members
13
13 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $357,720,644▲1.1% | $333,614,948▲1.0% | $606,628,308▲7.8% | $788,657,741▲5.0% | 990 |
| 2023 | $353,749,327▲2.2% | $330,337,653▲5.4% | $562,734,079▲10.1% | $750,835,911▲7.0% | 990 |
| 2022 | $346,271,530▲1.2% | $313,280,612▲7.8% | $510,895,212▲10.7% | $701,768,432▲7.0% | 990 |
| 2021 | $342,334,376▲3.4% | $290,499,670▲1.6% | $461,447,064▼0.2% | $655,709,010▼1.8% | 990 |
| 2020 | $331,132,598▲3.9% | $285,960,328▼6.5% | $462,534,537▲23.9% | $667,918,646▲19.5% | 990 |
| 2019 | $318,679,360▼4.3% | $305,692,076▲1.7% | $373,283,440▲3.9% | $558,856,219▲3.3% | 990 |
| 2018 | $332,879,981▲2.7% | $300,645,416▲7.4% | $359,430,001▲10.7% | $541,192,214▲9.0% | 990 |
| 2017 | $324,239,675▲12.5% | $280,048,886▲4.8% | $324,730,320▲14.7% | $496,726,502▲9.1% | 990 |
| 2016 | $288,329,755▲9.0% | $267,313,743▲15.0% | $283,172,895▲15.2% | $455,148,899▲9.7% | 990 |
| 2015 | $264,417,645▲14.6% | $232,357,200▲14.9% | $245,907,617▲7.9% | $414,895,604▲2.4% | 990 |
| 2014 | $230,734,267▲13.5% | $202,259,776▲2.7% | $227,832,604▲11.4% | $405,208,320▲10.7% | 990 |
| 2013 | $203,209,707 | $196,869,494▲11.0% | $204,538,592▲4.3% | $365,933,521▼1.1% | 990 |
| 2012 | — | $177,395,302▲14.9% | $196,050,926▲5.6% | $370,131,138▲11.6% | 990 |
| 2011 | — | $154,334,279▲14.9% | $185,684,856▲4.1% | $331,521,478▲0.8% | 990 |
| 2010 | — | $134,355,260▲6.2% | $178,314,220▲14.4% | $328,951,146▲10.5% | 990 |
| 2009 | — | $126,517,123 | $155,924,155 | $297,746,557 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Ronald T Piervincenzi — $975,149 (0.29% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Ronald T Piervincenzi | Chief Executive Officer & Ex-officio | 38 | $975,149 |
| Jakob Venema To 625 | Evp & Chief Science Officer | 38 | $618,546 |
| John A Giannone To 824 | Vp, Compendial Operations | 38 | $552,057 |
| Anthony P Lakavage | Secretary & Svp Glbl Ea | 38 | $545,170 |
| Amanda D Cowley | Svp, Legal, Strategy & People | 38 | $530,651 |
| Emily M Kaine | Svp, Gbl Health & Manufacturing Svcs | 38 | $527,212 |
| Stanley D Burhans | Chief Financial Officer | 38 | $507,875 |
| Venkat Surendra Nath Koduru | Svp Regions & Program Ops.(to 6/25) | 38 | $490,928 |
| Debra J Perez | Chief Equity Officer | 38 | $449,620 |
| Michael S Levy | Svp, Digital & Innovation | 38 | $441,812 |
| Bruk Alemayehu | Svp, Global Lab & Technical Ops | 38 | $430,208 |
| Fouad Atouf | Svp, Sci-glob Bio | 38 | $424,410 |
| Jennifer Devine | Svp, Doc Stds & Comp Policy | 38 | $419,352 |
| Dennis E Doherty Md | Convention President | 4 | — |
| Gregory E Amidon Phd | Pharmaceutical Sciences Trustee | 4 | — |
| Gwen Darien | Public Trustee | 4 | — |
| Jesse L Goodman Md Mph | Medical Sciences Trustee | 4 | — |
| John Taylor Jd | At Large Trustee | 4 | — |
| Julio Sanchez Y Tepoz Mscsjd | At Large Trustee | 4 | — |
| Krishna Reddy Nallamalla Md | At Large Trustee | 4 | — |
| Contractor | Services | Paid |
|---|---|---|
| Ruder Finn Inc | Consulting | $2,776,905 |
| Velocity Global LLC | Consulting | $2,390,094 |
| Ernst & Young LLP | Consulting | $2,066,599 |
| Abm Industry Groups LLC | Facilities Services | $1,978,299 |
| Bell Techlogix Inc | It Services | $1,587,324 |
8 grants to United States Pharmacopeial Convention Inc totaling $1.4M, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Jsi Research & Training Institute Inc | Operational support | 2023 | $169,332 |
| Jsi Research & Training Institute Inc | Operational support | 2022 | $476,593 |
| Jsi Research & Training Institute Inc | Operational support | 2021 | $261,783 |
| Jsi Research & Training Institute Inc | Operational support | 2020 | $258,897 |
| Jsi Research & Training Institute Inc | Operational support | 2019 | $18,174 |
| Path | Product development | 2015 | $89,026 |
| Path | Public health | 2015 | $41,043 |
| Path | Product development | 2014 | $45,567 |
17 grants totaling $256K in FY2024 — showing the 15 largest. All grants made by United States Pharmacopeial Convention Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Association For Accessible Medicines | Sponsorship - aam 2024 grx+ biosims | $32,700 |
| American Pharmacists Association Foundation | Apha 2025 annual meeting - sponsorship | $27,737 |
| Project Hope - the People-to-people Health Foundation Inc | Inaugural charity golf tournament sponsorship | $25,000 |
| Biohealth Innovation Inc | Charitable donation | $25,000 |
| Biohealth Innovation Inc | Newark mentoring movement | $20,000 |
| Mount Vernon Ladies Association of the Union | Charitable donation | $19,500 |
| Reagan-udall Foundation For the Food and Drug Administration | Annual innovations in regulatory science awards - sponsorship | $15,000 |
| Worldwide Business Research USA LLC | Logipharma us 2024 meeting - sponsorship | $12,000 |
| Alliance For Aging Research | Annual dinner sponsorship | $10,000 |
| Chpa Educational Foundation | Platinum level sponsorship | $10,000 |
| Northeastern Maryland Technology Council Inc | Bio mtc silver level sponsorship | $10,000 |
| National Consumers League Inc | Sponsorship ncl trumpeter awards dinner | $10,000 |
| American Association of Pharmaceutical Scientists | Aaps 2024 pharmsci 360 meeting - sponsorship | $10,000 |
| The American Society of Gene & Cell Therapy | Asgcr annual meeting - sponsorship | $8,600 |
| Arthritis Foundation Inc | Bronze level sponsorship | $8,000 |
Explore more
Data for United States Pharmacopeial Convention Inc (EIN 13-1656692) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.